Differential methylation in the circulation may predict the development of future T2D beyond traditional risk factors such as age and obesity3,8, but it may also be part of the biological mechanism that links age and/or obesity to glucose, insulin metabolism and/or T2D. The gene discussed is INS; the disease is obesity disorder.